Rchr
J-GLOBAL ID:200901066590514879
Update date: Sep. 24, 2024
Naoki Mori
モリ ナオキ | Naoki Mori
Affiliation and department:
Job title:
Professor
Homepage URL (1):
https://naokimori50.wixsite.com/mysite
Research field (3):
Cell biology
, Hematology and oncology
, Virology
Research keywords (11):
細胞浸潤
, 分子標的療法
, アポトーシス
, 転写因子
, 成人T細胞白血病/リンパ腫
, HTLV-1
, Cell invasion
, Molecular targetted therapy
, Apoptosis
, Transcription factor
, ATLL
Research theme for competitive and other funds (12):
- 2013 - 2016 IkappaB-zeta, a regulator of NF-kappaB, contributes to the pathogenesis of ATL
- 2009 - 2011 ATF3による成人T細胞白血病細胞運命制御
- 2008 - 2009 HTLV-1の発がん機構における遺伝子編集酵素AIDの関与
- 2007 - 2008 Expression of caveolin-1 in adult T-cell leukemia
- 2004 - 2006 Multiple cancer of the head and neck -viral infection and mismatch repair gene variation-
- 2004 - 2005 HTLV-I Tax dysregulates β-catenin signaling
- 2004 - 2005 蚊媒介性熱帯性ウイルス感染による神経・肝細胞死制御機構
- 2003 - 2003 デングウイルス感染により誘導される肝細胞アポトーシスの分子生物学的機序と病原因子
- 2002 - 2003 Involvement of Akt pathway in survival of HTLV-I-infected T cells.
- 2000 - 2001 Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor β singnaling
- 1998 - 1999 HTLV-I感染によるiNOS遺伝子発現誘導機構の解析
- 1992 - 1992 成人T細胞白血病に対する抗癌剤とサイトカイン併用療法に関する基礎的・臨床的研究
Show all
Papers (79):
-
Chie Ishikawa, Naoki Mori. FX1, a BCL6 inhibitor, reactivates BCL6 target genes and suppresses HTLV-1-infected T cells. Investigational new drugs. 2021
-
Chie Ishikawa, Naoki Mori. The antipsychotic drug pimozide is effective against human T-cell leukemia virus type 1-infected T cells. European journal of pharmacology. 2021. 908. 174373-174373
-
Chie Ishikawa, Masachika Senba, Naoki Mori. Importin β1 regulates cell growth and survival during adult T cell leukemia/lymphoma therapy. Investigational new drugs. 2020. 39. 2. 317-329
-
Chie Ishikawa, Naoki Mori. The anti-malaria agent artesunate exhibits cytotoxic effects in primary effusion lymphoma. Investigational new drugs. 2020. 39. 1. 111-121
-
Chie Ishikawa, Naoki Mori. The role of CUDC-907, a dual phosphoinositide-3 kinase and histone deacetylase inhibitor, in inhibiting proliferation of adult T-cell leukemia. European journal of haematology. 2020. 105. 6. 763-772
more...
MISC (58):
-
MALT1 as a novel therapeutic target for adult T-cell leukemia. 2019. S161
-
森直樹, 石川千恵. インポーチンβ1はKSHV感染原発性体腔液性リンパ腫の細胞増殖と生存を司る. 第67回日本ウイルス学会学術集会. 2019. P-DN-22
-
Naoki Mori, Chie Ishikawa. CUDC-907, a novel dual PI3K and HDAC inhibitor, blocks multiple signaling pathways in primary effusion lymphoma. 2019. 187
-
森直樹, 石川千恵. 成人 T 細胞白血病の新規治療標的 MALT1. 第6回日本HTLV-1学会学術集会プログラム集. 2019. 80
-
Naoki Mori, Chie Ishikawa. Evaluation of artesunate for the treatment of adult T-cell leukemia. 臨床血液. 2018. 59. 9. 1720-1720
more...
Books (11):
-
Challenge to the threat of invisible transmission: Global health security for the control of emerging infectious disease outbreaks
Nova Science Publishers 2016
-
Mechanisms of cancer formation under interplay between host immunity and human papillomavirus (HPV) infection
Nova Science Publishers 2016
-
Challenge to the threat of invisible transmission: global health security for the control of emerging infectious diseases outbreaks
2016
-
Pathogenesis of Kaposi sarcoma associated with human herpesvirus-8 infection
2012
-
Pathogenesis of Kaposi sarcoma associated with human herpesvirus-8 infection
2012
more...
Work history (2):
- 2002/04/01 - - , 琉球大学 医学研究科 教授
- 2002/04/01 - - , University of the Ryukyus, Graduate School of Medicine, Professor
Return to Previous Page